Through the construction of the CLL E-TCL1 mouse model, it was found that IDO1 and secretory IgM promote the expansion of MDSCs, but the inhibition of IDO1 could not reduce the recurrence of leukemia [85, 86]. This evidence concerns the gene IDO1 and B-cell chronic lymphocytic leukemia.